ASO Author Reflections: Predicting High-Risk Oncotype DX Recurrence Scores as a Strategy for Assessing Neoadjuvant Chemotherapy Eligibility
Crossref DOI link: https://doi.org/10.1245/s10434-018-6989-1
Published Online: 2018-10-30
Published Print: 2018-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Newman, Lisa
Text and Data Mining valid from 2018-10-30
Article History
Received: 23 October 2018
First Online: 30 October 2018